Latest filing published 22 Nov 2019 for Baudax Bio, Inc..
Insider track record
No signal scores available.
Recro Pharma, Inc.: trading record in brief
Recro Pharma, Inc. is a declared insider of Baudax Bio, Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, all for trades on 21 November 2019.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 22 November 2019 came the latest disclosure, a transaction in Baudax Bio, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Recro Pharma, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,211,145 shares0Common StockSEC:0001192482-19-000443:0
- 9,211,245 shares0Common StockSEC:0001192482-19-000443:1
2 of 2 declarations